 Boca Raton, Florida, Jan. 04, 2022 GLOBE NEWSWIRE -- INmune Bio, Inc. NASDAQ: INMB the Company, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that management will participate in two upcoming investor conferences and a medical meeting. Details of the event are as follows: 